ADNRX — American Beacon ARK Transformational Innovation Fund
Data updated: 2026-05-29
ADNRX — American Beacon ARK Transformational Innovation Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Thematic Equity · $156.87M AUM · 1.05% expense ratio · 42.7% 1-yr return. From SEC regulatory filings.
ADNRX Fund Overview
ADNRX — American Beacon ARK Transformational Innovation Fund is a US mutual fund managed by American Beacon Funds, categorised as United States Thematic Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: American Beacon Funds
- Category: United States Thematic Equity
- Assets under management: $156.87M
- 1-year return: 42.7%
- Ticker: ADNRX
- SEC CIK: 0000809593
- SEC series ID: S000056147
- Share class ID: C000224371
ADNRX Holdings
Top 10 holdings of American Beacon ARK Transformational Innovation Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Tesla Inc | 10.39% |
| CRISPR Therapeutics AG | 6.19% |
| Tempus AI Inc | 5.13% |
| Shopify Inc | 4.80% |
| Circle Internet Group Inc | 4.53% |
| Coinbase Global Inc | 4.44% |
| Robinhood Markets Inc | 4.27% |
| Advanced Micro Devices Inc | 4.11% |
| Roku Inc | 4.04% |
| ROBLOX Corp | 3.58% |
ADNRX Portfolio Allocation
Asset-class allocation of American Beacon ARK Transformational Innovation Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.1% |
| Cash & Equivalents | 2.2% |
ADNRX Performance
Total returns for ADNRX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -11.8% |
| 1 year | 42.7% |
| 3 years (annualised) | 19.1% |
| 5 years (annualised) | -9.9% |
ADNRX Risk Information
Risk metrics for ADNRX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 33.1%
ADNRX Costs and Fees
ADNRX costs about $105 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.05%
- Gross expense ratio: 1.18%
- Portfolio turnover: 46%
- Brokerage commissions: 3.54 bps of average net assets (SEC N-CEN)
ADNRX Cashflows
Over the 12 months to 2026-03, American Beacon ARK Transformational Innovation Fund had net outflows of $61.59M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$4.18M |
| 2026-02 | −$4.64M |
| 2026-01 | −$8.68M |
| 2025-12 | −$4.35M |
| 2025-11 | −$5.10M |
| 2025-10 | −$5.96M |
ADNRX Debt Constituents
No individual debt constituents are reported in American Beacon ARK Transformational Innovation Fund's latest SEC N-PORT filing.
ADNRX Prospectus and SEC Filings
Official American Beacon ARK Transformational Innovation Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Thematic Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.